Zotepine versus placebo for schizophrenia

4Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To review the effects of zotepine compared with placebo for people with schizophrenia or related psychoses. As secondary objectives, we propose to investigate whether people: with schizophrenia described as 'treatment resistant' differed in their response from those whose illness was not designated as such; having predominantly positive or negative symptoms of schizophrenia were more responsive to zotepine than those without this designation; and experiencing their first episode of schizophrenia differed in their response from those at a later stage of their illness.

Cite

CITATION STYLE

APA

Dickenson, R., & Fenton, M. (2013). Zotepine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, 2013(7). https://doi.org/10.1002/14651858.CD010644

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free